(Press-News.org) MINNEAPOLIS/ST. PAUL (11/10/2023) — Researchers from the University of Minnesota Medical School examining the cause of cardiomyopathy discovered one out of every six patients with coronary artery disease had non-ischemic or dual cardiomyopathy.
The findings of this study were published this week in the peer-reviewed journal Circulation, the flagship journal of the American Heart Association.
Cardiomyopathies are diseases of the heart muscle. Patients with coronary artery disease can have cardiomyopathy from heart muscle damage as a result of heart attacks. Therefore, in patients with cardiomyopathy, the current clinical practice is to look for coronary artery disease using coronary angiography—an X-ray test that shows whether coronary arteries are narrowed or blocked. If coronary artery disease is found, it is assumed the patient has ischemic cardiomyopathy.
Non-ischemic cardiomyopathy refers to a heart muscle condition where the cause of the problem is not related to blood supply. Dual cardiomyopathy refers to two simultaneous problems with the heart muscle—both ischemic and non-ischemic. Patients with these conditions had worse long-term outcomes compared with patients with ischemic cardiomyopathy.
The research team studied patients with coronary artery disease who had cardiac magnetic resonance imaging (CMR) for clinical reasons, which allowed a more accurate determination of the presence and the cause of cardiomyopathy.
“Investigating the cause of cardiomyopathy using CMR for a myocardium-centric approach—in contrast to the conventional coronary-centric approach using coronary angiography—provided us new insights with important clinical implications,” said Chetan Shenoy, MBBS, MS, senior author of the paper, an associate professor at the University of Minnesota Medical School and a cardiologist with M Health Fairview. “Our findings have implications for the treatment of patients with coronary artery disease and cardiomyopathy, traditionally assumed to all have ischemic cardiomyopathy.”
The findings imply that in patients with obstructive coronary artery disease, coincidental non-ischemic or dual cardiomyopathy may contribute to the lack of prognostic benefit from coronary revascularization—procedures which restore blood flow to areas of the heart that are not getting enough blood.
Future research should investigate whether non-ischemic or dual cardiomyopathy in patients with coronary artery disease influences outcomes, specifically after coronary revascularization. If it does, the next step would be to investigate whether routine CMR before coronary revascularization to identify the cause of cardiomyopathy would improve the selection of patients for coronary revascularization, and overall outcomes.
This research was supported by the National Institutes of Health [grants K23HL132011, R03HL157011, and R01HL158756].
###
About the University of Minnesota Medical School
The University of Minnesota Medical School is at the forefront of learning and discovery, transforming medical care and educating the next generation of physicians. Our graduates and faculty produce high-impact biomedical research and advance the practice of medicine. We acknowledge that the U of M Medical School, both the Twin Cities campus and Duluth campus, is located on traditional, ancestral and contemporary lands of the Dakota and the Ojibwe, and scores of other Indigenous people, and we affirm our commitment to tribal communities and their sovereignty as we seek to improve and strengthen our relations with tribal nations. For more information about the U of M Medical School, please visit med.umn.edu.
END
University of Minnesota Medical School researchers investigate cause of cardiomyopathy in coronary artery disease using cardiac MRI
2023-11-10
ELSE PRESS RELEASES FROM THIS DATE:
Heart of Gold: Bath student team wins world Heart Hackathon competition
2023-11-10
Student engineers from the University of Bath are on top of the world after winning an international competition to design an artificial heart.
Team Bath Heart took top prize at the grand final of the first-ever Heart Hackathon, which was held in Texas at the end of October.
Six members of the team presented their device to global experts in artificial heart technologies, competing against teams from Australia, the United States, Sweden, New Zealand, Romania and Egypt.
The ‘total artificial heart’ ...
Cleveland Clinic research links sleep apnea to increased risk of atrial fibrillation
2023-11-10
New research from Cleveland Clinic has identified a link between sleep apnea and the development of atrial fibrillation, a common heart rhythm disorder.
Published in JAHA, the study of over 42,000 patients found that sleep-related hypoxia - or low oxygen levels during sleep - is associated with a higher risk of developing atrial fibrillation over time. The study found this risk persisted even after accounting for lung function, suggesting sleep-related hypoxia independently increases atrial fibrillation risk separate from any underlying lung disease.
Atrial fibrillation causes an irregular ...
New approach to pancreatic cancer treatment expands therapeutic possibilities, shows promise for increased survival
2023-11-10
Preclinical research published in the Journal for ImmunoTherapy of Cancer points to a promising new treatment option for people with pancreatic cancer. Researchers from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) suggest that when used in a form that can be delivered directly into the tumor cell, polyinosine–polycytidylic acid (pIC) suppresses tumor growth, induces cancer cell death and enhances survival in animal models with the most common form of pancreatic cancer.
Researchers also concluded that when used alone ...
UTHealth Houston partners with Mexican organizations for $5 million NIH grant to improve implementation of cancer control interventions in Mexico and Latin America
2023-11-10
A five-year, $5 million grant has been awarded by the National Cancer Institute (NCI) to the UTHealth Houston Institute for Implementation Science to support research and training in implementation science, with a focus on improving cancer control efforts in Mexico and Latin America.
The grant brings together researchers from UTHealth Houston, the Mexican National Institute of Public Health (INSP), the Mexican National Cancer Institute (INCan), and the University of California San Francisco (UCSF).
The grant will fund a new center, LISTOS for Cancer Control – Leveraging Implementation ...
Yucatán’s underwater caves host diverse microbial communities
2023-11-10
Cave divers collected 78 water samples throughout the complex web of underwater caves
Researchers found the cave system’s microbiome is distinct from the nearby sea
Microbial communities vary between cave systems forming distinct “neighborhoods”
EVANSTON, Ill. — With help from an experienced underwater cave-diving team, Northwestern University researchers have constructed the most complete map to date of the microbial communities living in the submerged labyrinths beneath Mexico’s Yucatán Peninsula.
Although previous researchers have collected water and microbial samples from the ...
A catalyst for change: New research aims to design atomically efficient and selective catalysts
2023-11-10
Most of us understand that electrical engineering and mechanical engineering play a key role in running our washing machines or our computers. But did you know that more than 80 percent of the products we use every day, such as fertilizers, cosmetics, fragrances, rubber and more, require some sort of chemical catalyst while being manufactured?
Catalysts are like turbochargers for chemical reactions. Until now, the process of designing a catalyst for chemical reactions has been mostly trial ...
Study finds tapering TNF inhibitors increases flares, lowers boolean remission rates for RA patients in remission
2023-11-10
ATLANTA — New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, found that rheumatoid arthritis (RA) patients in sustained remission who stopped TNF inhibitors (TNFi) had significantly more flares and lower Boolean 2.0 remission rates compared with those who continued treatment. Boolean 2.0 is a revised definition for evaluating disease activity in RA that classifies more patients as achieving remission than Boolean 1.0. It is endorsed by the American College of Rheumatology and the European Alliance for Associations in Rheumatology (EULAR) (Abstract #L07).
As more RA patients ...
Study shows stem cell transplant significantly improves outcomes in refractory juvenile systemic sclerosis
2023-11-10
ATLANTA — New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that patients with refractory juvenile systemic sclerosis improved significantly on nearly all measures for two years following autologous stem cell transplant (Abstract #L06).
Juvenile-onset systemic sclerosis (jSSc), also called scleroderma, is a disfiguring autoimmune disorder marked by hardening of the skin and internal organs, including the digestive tract, lungs, musculoskeletal system, kidneys and heart. The psychological and physical effects of the disease persist into adulthood, and many patients have a shortened lifespan. Effective ...
Adolescent and young adult sex workers more likely to experience muscle dysmorphia
2023-11-10
Using data from over 900 participants in a large, diverse, and national sample of Canadian adolescents and young adults from the Canadian Study of Adolescent Health Behaviors, a new study published in the journal Sexual Health researchers found significant associations between sex work and muscle dysmorphia.
Sex work, in its various forms, is highly stigmatized in Canadian society, and sex workers are often victims of harmful stereotypes. It is estimated that roughly 4% of Canadian adolescents engage in selling sex, and research has shown that those involved in sex work are more at risk to experience substance use ...
Proteins and Networks: Bonn neuroscientist receives 1.2 million dollars for research into psychiatric disorders
2023-11-10
Neurodegenerative diseases like Alzheimer’s and Parkinson’s can be associated to depression and anxiety. Dr. Sabine Krabbe, a neuroscientist at DZNE’s Bonn site, is receiving 1.2 million US dollars from the Chan Zuckerberg Initiative to understand the mechanisms involved in the onset of these syndromes. To this end, she aims to examine the function of the brain’s “emotion center” using new methodologies to examine the function of single cells in experimental mouse models. The study will run for four ...